VIVOLTA offers the MedTech and Pharma industry groundbreaking nanofiber-based solutions that guide the human body to heal itself. We enable patients, suffering from an impaired quality of life due to congenital defects, trauma or aging, to benefit from the most innovative and sustainable medical solutions. As thought leader, VIVOLTA is setting the worldwide standard for electrospun nanofiber-based medical devices, tissue engineering products, and drug delivery solutions. Utilizing its fully automated MediSpin® technology platform, production of VIVOLTA’s solutions is both consistent, reproducible and scalable. Importantly, the MediSpin® platform, protected by seven patent families, meets the guidelines described in the first ASTM standard for fiber-based medical scaffolds (F3510-21), which VIVOLTA co-authored.